Assessment of the Cost Effectiveness of Travoprost versus Latanoprost as Single Agents for Treatment of Glaucoma in France

Author： Payet Stéphanie  

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.28, Iss.3, 2008-01, pp. : 183-198

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cost Effectiveness of Travoprost versus a Fixed Combination of Latanoprost/Timolol in Patients with Ocular Hypertension or Glaucoma: Analysis Based on the UK General Practitioner Research Database

By Renato De Natale  

Clinical Drug Investigation, Vol. 29, Iss. 2, 2009-01 ,pp. : 111-120

Adis International

Access to resources Recommend Favorite

Efficiency of Travoprost versus Fixed-Combination Latanoprost/Timolol

By Soto Javier  

Clinical Drug Investigation, Vol. 29, Iss. 8, 2009-08 ,pp. : 557-557

Adis International

Access to resources Recommend Favorite

Travoprost/timolol looks to be cost saving in glaucoma

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 515, 2006-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Travoprost – a new prostaglandin analogue for the treatment of glaucoma

By Whitson Jess T  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 965-977

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Fluvoxamine in the Treatment of Recurrent Depression in France

By Nuijten M.  

PharmacoEconomics, Vol. 14, Iss. 4, 1998-10 ,pp. : 433-445

Adis International

Access to resources Recommend Favorite